The ubiquitin–proteasome system plays important roles in maintaining the self-renewal and differentiation of stem and progenitor cells through highly ordered degradation of cellular proteins. Fbxw11, an E3 ligase, participates in many important biological processes by targeting a broad range of proteins. However, its roles in hematopoietic stem/progenitor cells (HSPCs) have not been established.
In this study, the effects of Fbxw11 on HSPCs were studied in vitro and in vivo by an overexpression strategy. Real-time PCR was performed to detect the expression of Fbxw11 in hematopoietic subpopulations. Colony-forming assays were performed to evaluate the in vitro function of Fbxw11 on HSPCs. Hoechst 33342 and Ki67 staining was performed to determine the cell-cycle distribution of HSPCs. Competitive transplantation experiments were used to evaluate the effect of Fbxw11 on the reconstitution potential of HSPCs. Single-cell RNA sequencing (scRNA-seq) was employed to reveal the transcriptomic alterations in HSPCs.
The expression of Fbxw11 was higher in Lin−c-Kit+Sca-1+ (LSK) cells and myeloid progenitors than in lymphoid progenitors. Fbxw11 played negative roles in colony-forming and quiescence maintenance of HSPCs in vitro. Furthermore, serial competitive transplantation experiments revealed that Fbxw11 impaired the repopulation capacity of HSPCs. The proportion of granulocytes (Gr-1+CD11b+) in the differentiated mature cells was significantly higher than that in the control group, T cells and B cells were lower. Moreover, scRNA-seq revealed seven cell clusters in HSPCs. In addition, Fbxw11 downregulated the expression of Cebpa, Myc and Arid5b, which are significant regulators of HSPC activity, in most cell clusters.
Our data demonstrate that Fbxw11 plays a negative role in the maintenance of HSPCs in vitro and repopulation capacity in vivo. Our data also provide valuable transcriptome references for HSPCs in homeostasis.
Self-renewal and differentiation are two essential functions of hematopoietic stem cells (HSCs) to maintain the homeostasis of the entire hematopoietic system under physiologic and pathologic conditions . These two functions are well balanced by sophisticated mechanisms [2, 3], and breaking the balance results in blood diseases [4, 5]. The ubiquitin–proteasome system (UPS), which controls the degradation of proteins with a short half-time, is a key player in maintaining the balance and is involved in normal and malignant hematopoiesis . F-box family proteins, which are further divided into Fbxw, Fbxl and Fbxo subfamilies based on protein structure, determine the specificity of UPS degradation by identifying a specific spectrum of target proteins for ubiquitination . F-box family proteins are widely involved in hematopoietic regulation, and their abnormal expression or dysfunction results in deteriorations in hematopoietic homeostasis and even malignancies . Fbxw7 maintains HSC quiescence to preserve self-renewal potential in normal hematopoiesis . Fbxw7, Fbxl2, Fbxl10 and SKP2 regulate the proliferation of leukemia cells through the ubiquitination pathway [10,11,12]. Loss-of-function mutations of Fbxw7 are involved in both leukemogenesis and leukemic progression by affecting the ubiquitination and half-life of c-Myc protein, which is essential for the maintenance of HSC quiescence [13, 14]. Deletions or loss-of-function mutations of Fbxo11 contribute to the pathogenesis of diffuse large B-cell lymphomas . However, the roles of F-box proteins in hematopoiesis are not fully understood.
Fbxw11 participates in many important biological processes, including proliferation, differentiation, development and metabolism, by targeting a broad range of substrates for degradation [16, 17]. Fbxw11 is involved in cell proliferation by modulating the activities of cycle-related transcription factors and regulators. However, the effects of Fbxw11 on cell proliferation, either stimulatory or inhibitory, seem to be cell type dependent since the substrates of Fbxw11 cover both cell cycle activator and suppressors. In our previous studies, Fbxw11 is upregulated in acute lymphocytic leukemia, and high level of Fbxw11 expression promotes the proliferation of leukemia cells . Cell cycle regulation is very important for HSCs to maintain self-renewal and engraftment potential. Hence, how Fbxw11 impacts the proliferation, repopulation and self-maintenance of normal HSPCs is of interest. Furthermore, HSPCs are heterogeneous and can be divided into functionally hierarchical subpopulations . Recent evidence defined HSPC subpopulations by their transcriptomic landscapes and revealed the diversity among them at single-cell resolution [20,21,22,23]. However, how Fbxw11 affects HSPC subpopulations at single-cell resolution has not been elucidated.
In the present study, the in vitro and in vivo effects of Fbxw11 on HSPCs were studied by overexpressing Fbxw11 in HSPCs. Furthermore, single-cell RNA sequencing (scRNA-seq) was employed to explore the transcriptomic heterogeneity of HSPCs and gene expression profiling alterations by Fbxw11 at the single-cell level. This work contributes to the comprehensive understanding of the effects of Fbxw11 on hematopoietic regulation and provides valuable transcriptome references for HSPCs in homeostasis.
Materials and methods
Seven- to eight-week-old female B6.SJL (CD45.1) and C57BL/6 (CD45.2) congenic mice were provided by the Animal Centre of the Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, and maintained in an SPF-certified facility. All procedures for animal experiments were approved by the Institutional Animal Care and Use Committee at the institute.
The retroviral vector pMSCV-PGK-GFP was previously used in our laboratory [24, 25]. The recombinant vectors were constructed by inserting murine Fbxw11 variants into pMSCV-PGK-GFP. The blank vector was used as a control.
Isolation of cells
Bone marrow (BM) cells were obtained from the tibia and femur of 8-week-old mice. The markers and strategies for the isolation of hematopoietic cells were described previously [25,26,27,28,29]. For Lin−c-Kit+Sca-1+ (LSK) cells, Lin−c-kit+ (LK) cells, long-term hematopoietic stem cells (LT-HSCs), short-term hematopoietic stem cells (ST-HSCs), multipotent progenitors (MPPs), common myeloid progenitors (CMPs), granulocyte–monocyte progenitors (GMPs), megakaryocyte–erythroid progenitors (MEPs) and common lymphoid progenitors (CLPs), the c-kit+ cells were first enriched with microbeads according to the manufacturer’s guidelines (Miltenyi Biotec, Bergisch Gladbach, Germany, 130–091-224). Then, cells were stained with V450-Lin (Ter119, Gr-1, CD11b, B220, CD3, CD4, CD8), PE-Cy7-c-Kit, APC-Sca-1, Percp-Cy5.5-CD34, PE-Flk2, PE-CD16/32 and PE-IL7R antibodies before flow cytometric cell sorting following the strategies shown in Additional file 1: Fig. S1A–B. For granulocytes, macrophages and monocytes, BM cells were stained with Percp-Cy5.5-CD3, Percp-Cy5.5-CD19, BV-421-Gr-1, APC-Cy7-CD11b, PE-CD115 and APC-F4/80 antibodies before flow cytometric cell sorting following the strategies shown in Additional file 1: Fig. S1C–D. For B cells, T cells and NK cells, splenic cells were stained with Percp-Cy5.5-CD3, PE-B220, PE-Cy7-CD4, APC-Cy7-CD8, PE-Cy7-NK1.1 and APC-NKP46 before flow cytometric cell sorting following the strategies shown in Additional file 1: Fig. S1E–F. All antibodies are summarized in Additional file 2: Table S1, and cell staining was performed following standard protocols.
The retroviruses were harvested following standard protocols. Prior to virus infection, LSK or LK cells from C57BL/6 mice were prestimulated for 16 h in StemSpan SFEM (STEMCELL Technologies, Vancouver, BC, Canada) supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin, 100 ng/ml SCF, 20 ng/ml TPO, 10 ng/ml IL-3 and 10 ng/ml IL-6. (All cytokines were purchased from PeproTech, Rocky Hill, NJ.) Then, the cells were infected twice in 2 ml of virus stock containing 8 µg/ml polybrene at one-day intervals. After sorting by flow cytometry, GFP+ LSK cells were named LSK-Fbxw11c, LSK-Fbxw11d and LSK-Con.
Flow cytometric analysis and cell sorting
Cells were resuspended for FACS analysis using a FACS Canto II or sorting using a FACS ARIA III (BD Biosciences, San Jose, CA) following standard protocols. The FACS data were analyzed using FlowJo software or BD FACS Diva Software.
GFP+ cells were sorted 48 h after LSK cells were infected with recombinant or control retrovirus. Five hundred GFP+ cells were plated in each well in MethoCult GF M3434 medium (Stem Cell Technologies, Vancouver, BC, Canada) and cultured for 10 days according to the manufacturer’s instructions. Colonies were counted under a microscope.
GFP+ cells were sorted 48 h after LK cells were infected with recombinant or control retrovirus. GFP+ cells (1 × 106) were transplanted into lethally irradiated (9.5 Gy) recipient mice (CD45.2). After 16 h, the recipient mice were killed, and the BM GFP+ donor cells were analyzed by FACS.
Competitive transplantation assay
GFP+ LSK cells were sorted 48 h after LSK were infected with recombinant or control retrovirus. In the first round of transplantation, 1 × 104 GFP+ LSK cells (CD45.1+) were transplanted with 2 × 105 competitor cells (CD45.2+ BM cells) into lethally irradiated recipients (CD45.2). The percentage of GFP+ cells in the peripheral blood (PB) was monitored monthly by FACS for 5 months. The mice were killed, and BM cells were collected. The percentage of different lineages in GFP+ cells was assessed by FACS. In the second round of transplantation, 2 × 105 GFP+ cells from the first round of recipients (CD45.1+) were transplanted with 2 × 105 competitor cells (CD45.2+) into lethally irradiated female recipients (CD45.2+).
Cell cycle analysis
The cell cycle of GFP+ LSK cells was analyzed 48 h after LSK cells were infected with recombinant or control retrovirus. Briefly, cells were first stained with V450-Lineage, PE-Cy7-c-kit and APC-Sca-1. Then, cells were treated with Cytofix/Cytoperm buffer followed by Perm/Wash buffer (BD Pharmingen) and stained with PE-Ki-67. Finally, cells were resuspended in staining buffer with Hoechst 33342 (Sigma) before analysis by FACS following standard protocols.
Total RNA was extracted from GFP+ LSK cells that had been infected with recombinant or control retrovirus using TRIzol Reagent (ThermoFisher, Carlsbad, CA, USA). cDNA was synthesized using M-MLV reverse transcriptase (Thermo Fisher) according to the manufacturer’s instructions. Real-time PCR was performed using an ABI Q5 Sequence Detector System (Applied Biosystems, Foster City, CA). The relative level of target genes was calculated using the ΔΔCt method. The sequences of all primers are listed in Additional file 3: Table S2.
Total protein was extracted from LSK-Fbxw11c, LSK-Fbxw11d and LSK-Con using lysis buffer (Cell Signaling Technology, Danvers, MA) supplemented with protease inhibitors 72 h after retroviral infection. Proteins were separated by 10% SDS–polyacrylamide gel electrophoresis and transfer to polyvinylidene difluoride (PVDF) membrane. PVDF membranes were incubated with diluted primary antibodies (1:1000 for Fbxw11; ab188511, Abcam, Cambridge, UK) and 1:5000 for glyceraldehyde 3-phosphate dehydrogenase (GAPDH; 97166, Cell Signaling, Danvers, MA) in TBST buffer containing 5% milk at 4℃ overnight. ChemiDoc™ imaging system (Bio-Rad) was used for chemiluminescent visualization of proteins after incubating with secondary antibodies. Results were quantified by gray value analysis (Image J).
10× Genomics single-cell RNA sequencing (scRNA-seq)
GFP+ LSK cells were collected 48 h after LSK were infected with recombinant or control retrovirus. Cell viability was assessed by an TC10 automated cell counter (Bio-Rad). Then, the library preparation procedures were performed according to the instructions of the manufacturer of the Chromium Single Cell 3′ Reagent Kit v2. (10X Genomics, Inc). The libraries were quantified and sequenced via Illumina NextSeq 550 at Novogene Co., Ltd., Beijing, China. The RNA-seq data that support the findings of this study have been deposited in the Gene Expression Omnibus (GEO) under accession number GSE160643.
scRNA-seq-based data analysis
The quality of paired-end raw reads was checked with FastQC, and the low-quality reads, adapter sequences and reads that could not form pairs were removed using Trimmomatic . Cell Ranger software (version 3.1.0, 10X Genomics) was then used to process alignment, barcode and UMI counting. The cleaned reads were mapped to the UCSC mouse reference genome (mm10) using the STAR  program that was included in the Cell Ranger pipeline, and the reads were separated into exonic (overlap with an exon > 50%), intronic (non-exonic and overlap with an intron) and intergenic reads based on the transcript annotation GTF (GRCm38 Ensembl 84). The exonic locus was prioritized when the reads were aligned to multiple loci. The exonic reads were further aligned to the annotated transcripts, and the reads that were uniquely mapped to the transcriptome were used for UMI counting to generate a gene-barcode matrix. Downstream data analysis was performed with the filtered gene-barcode matrix using the Seurat (version 3.0) R package . Low-quality cells or empty droplets that had fewer than 500 genes and genes that were expressed in fewer than 3 cells were excluded, and 2000 highly variable genes identified using local polynomial regression were selected for the next step. Next, a linear transformation was used to scale the expression of each gene, and principal component analysis was performed on scaled data for dimension reduction. The number of statistically significant principal components was determined by ElbowPlot. A K-nearest neighbor graph was constructed based on Euclidean distance in reduced dimension space, and the Louvain algorithm with the resolution parameter 0.4 was applied to identify different clusters. The t-distributed stochastic neighbor embedding (t-SNE) was used to visualize the clusters. Differential expression analysis was performed using a Wilcoxon rank sum test to identify cluster-specific markers, and the differentially expressed genes (DEGs) were reported if the adjusted p value was < 0.05 and the log fold change was greater than 0.25. The scaled expression levels of markers across different clusters are displayed in a heatmap.
Monocle2  was used to perform single-cell trajectory analysis. The Seurat object was converted into Monocle2 object followed by the calculation of normalization factor and dispersion. Then, DEGs were calculated and we selected DEGs with q-value < 0.01 for dimension reduction. Finally, we ordered the cells and got the pseudotime trajectory.
All quantitative data are presented as the means ± SD. A t test was used to compare two sets of quantitative data. One-way analysis of variance (ANOVA) followed by Dunnett’s post hoc multiple comparison test was used for univariate comparisons among multiple sets. Two-way ANOVA followed by Bonferroni’s post hoc test was also used to analyze multiple factors. Data were analyzed using GraphPad Prism software. Two-sided p values < 0.05 were considered statistically significant.
Distribution of Fbxw11 in hematopoietic cell populations
The hematopoietic cell populations were sorted by FACS following the strategies shown in Additional file 1: Fig. S1. The expression of Fbxw11 (covering all isoforms) in HSPC subpopulations, including LT-HSCs, ST-HSCs, LSK cells, MPPs, CMPs, GMPs, MEPs and CLPs, was first studied by quantitative real-time PCR. The expression of Fbxw11 was lower in purified murine LT-HSCs than in total BM samples. However, higher levels of Fbxw11 expression were observed in purified ST-HSCs, LSK cells, MPPs, CMPs, GMPs and MEPs, especially in GMPs, than in BM samples. Among the committed progenitors, Fbxw11 was expressed at higher levels in MPPs, GMPs and MEPs than in CLPs (Fig. 1A). Then, the expression of Fbxw11 in mature blood cells was examined. The results showed that higher levels were observed in macrophages and NK cells, whereas lower levels were detected in CD4 T cells (Fig. 1B). Collectively, the results show that Fbxw11 is differentially expressed among HSPC subpopulations, which suggests that Fbxw11 may play different roles among HSPC subpopulations.
Fbxw11 plays a negative role in the maintenance of HSPCs in vitro
Although Fbxw11 is expressed as three transcript variants in humans and four variants in mice through alternative splicing [34, 35], only Fbxw11c and Fbxw11d were expressed mouse BM samples . Therefore, LSK cells were transfected with recombinant retroviruses carrying Fbxw11c and Fbxw11d, respectively. High-level expression of Fbxw11 in LSK-Fbxw11c and LSK-Fbxw11d was verified by real-time RT-PCR and Western Blot (Fig. 2A, B). Colony-forming assays were performed to evaluate the in vitro function of LSK-Fbxw11c and LSK-Fbxw11d cells. Fbxw11 variants decreased the number of total colonies as well as GM, G and M colonies, indicating that Fbxw11 impaired the colony-forming ability of LSKs in vitro (Fig. 2C). However, the inhibition degrees varied among different kinds of colonies. An increase in the proportion of CFU-GM colonies in total colonies was observed (Fig. 2D). Analysis of GMPs 48 h after LSK cells were infected with retroviruses also demonstrated that Fbxw11 variants increased the percentage of GMPs (Fig. 2E). In order to know whether the in vitro impaired the maintenance of HSPCs by Fbxw11 variants was associated with changes in cell quiescence, a fundamental characteristic of stem cells, Ki-67 and Hoechst 33342 staining experiments were performed. The results demonstrated that the percentage of G0 stage cells (Ki-67−) was lower in LSK-Fbxw11c or LSK-Fbxw11d than in LSK-Con, suggesting that Fbxw11 promoted HSPCs to exit the quiescent state (Fig. 2F). Furthermore, the expression of stem cell homeostasis and proliferation-associated genes was evaluated. Interestingly, the expression levels of HoxA5, Hoxbl3, Myc, Oct4, Sox2 and Tim1 were significantly decreased in LSK-Fbxw11c and LSK-Fbxw11d (Fig. 2G). By contrast, upregulation of CyclinD3, which plays positive roles in proliferation, and downregulation of Cdkn1c, which plays negative roles in proliferation, were detected in LSK-Fbxw11c and LSK-Fbxw11d (Fig. 2H). These studies suggest that Fbxw11 may play a negative role in the maintenance of HSPCs in vitro, which may be associated with decreased quiescence of HSPCs.
Fbxw11 reduces the in vivo repopulating capacity of HSPCs at steady state
Competitive transplantation experiments were used to evaluate the effect of Fbxw11 on the reconstitution potential of HSPCs. The experimental design is shown in Fig. 3A. LK cells were used for the homing assay. The results showed that Fbxw11 variants had little effect on the homing capacity of LK cells (Additional file 1: Fig. S2A). LSK cells were used for a competitive transplantation assay. Fbxw11 variants decreased the repopulation potential of LSK cells one month after transplantation as assessed by the percentage of PB GFP+ donor cells in recipient mice (Fig. 3B). The reconstruction potential of LSK cells was further monitored by PB GFP+ cells for five months, showing that Fbxw11 variants decreased the engraftment of LSK cells throughout the experimental period (Fig. 3C). The reconstitution levels in the BM and spleen were assessed as GFP+ cells five months after transplantation. Lower reconstitution levels were observed in the Fbxw11 groups than in the control group (Fig. 3D). The overall reconstitution status (GFP+ cells and competitor cells) was assessed at the 1st, 3rd and 5th month after first-round transplantation, and no significant differences were detected among the three groups (Additional file 1: Fig. S2B–D). GFP+ cells from first-round recipients were isolated five months after the first BM transplantation and transplanted into secondary recipients. PB engraftment was monitored for 4 months. Fbxw11 variants significantly decreased long-term reconstitution in the secondary recipients (Fig. 3E). The reconstitution of BM donor-origin LSK cells was analyzed to see the effects of Fbxw11 on HSPCs. As expected, the reconstitution rate of LSK cells in Fbxw11-overexpressing group was significantly lower than the control group (Additional file 1: Fig. S2E). Taken together, these observations suggest that Fbxw11 reduces the repopulating capacity of HSPCs and long-term self-renewal of HSCs in vivo.
Effects of Fbxw11 on the proportion of differentiated mature cells after transplantation
Multilineage differentiation is a key biological property of HSCs. The PB GFP+ donor cells in the competitive transplantation experiments were further analyzed by lineages one month after first-round transplantation. The percentage of B220+ B lymphocytes and CD3+ T lymphocytes was lower in the LSK-Fbxw11c or LSK-Fbxw11d group than in the control group (Fig. 4A), whereas the percentage of Gr-1+ CD11b+ granulocytes was higher in the LSK-Fbxw11c or LSK-Fbxw11d group than in the control group (Fig. 4B). GFP+ donor cells from the PB, BM and spleen were also assessed by lineages five months after first-round transplantation. Similar results were obtained (Fig. 4C–E). It was reported that CSF1R, CSF2R and RUNX1 are important regulators of myeloid cells. Upregulation of Csf1r, Csf2r and Runx1 was detected in the LSK-Fbxw11c and LSK-Fbxw11d groups (Fig. 4F). Collectively, these data demonstrated that the effects of Fbxw11 on myeloid and lymphoid cells varied and implied that Fbxw11 might play more important roles in myeloid cells than lymphoid cells. Fbxw11d was chosen for further study hereafter since the above results demonstrated little difference between Fbxw11c and Fbxw11d.
Single-cell analysis of the effects of Fbxw11 on heterogeneous HSPC subpopulations
To determine the effects of Fbxw11 on the gene expression profile and composition of normal HSPCs, scRNA-seq was performed using 10× Genomics. As shown in Fig. 5A, LSK-Con and LSK-Fbxw11d were sorted after infection. In total, 5297 LSK-Con cells and 6932 LSK-Fbxw11d cells passed all the quality control filters and were first analyzed using Cell Ranger. These cells (12,229 cells) were put into one group for analyses. The median number of genes per cell was 4169. Principal component analysis (PCA) and t-SNE revealed significant transcriptional heterogeneity within LSK cells, which were divided into 7 major cell clusters (Fig. 5B). Trajectory analysis showed that cluster 1 and cluster 0 represented populations of more primitive stem cells, and other clusters were split into two branches which showed the myeloid and lymphoid lineages (Fig. 5C). The heatmap of cluster-specific genes (top 10 DEGs for cluster 0 to cluster 3) in different clusters is shown in Fig. 5D. Their expression is also shown as a violin plot (Additional file 1: Fig. S3).
To unravel which established HSPC populations corresponded to these cell clusters, two published scRNA-seq datasets were used as references [21, 22]. Population-specific genes of different transcriptionally defined HSPC populations, i.e., tHSC1 to tHSC3 and tMPP1 to tMPP5, were obtained [21, 22], and the expression of the population-specific genes in 7 cell clusters is shown in heatmaps (Additional file 1: Fig. S4). Cluster 1 corresponded to primitive HSCs since they expressed higher levels of tHSC1- and tHSC2-specific genes. Furthermore, among the top ten specific genes of cell cluster 1, Myct1 and Ly6a were tHSC1-specific genes, and Ltb was a tHSC2-specific gene . In addition, expression of the top ten specific genes of cell cluster 1 was also analyzed by the published Web tool (http://blood.stemcells.cam.ac.uk/single_cell_atlas.html) . Three genes, i.e., Ltb, Myct1 and Serpina3g, were mainly expressed in more primitive HSCs, including LT-HSCs (Additional file 1: Fig. S5). It is worth noting that cluster 1 cells expressed high levels of Hbb-bt, Ctla2a, S100a4, Vamp5, S100a6 and Car2, which did not appear in the population-specific genes tHSC1, tHSC1 [21, 22] or LT-HSC . Cluster 0 corresponded to the tMPP1 population . They shared specific genes, i.e., Ube2c, Cenpf, Top2a, Cdk1 and Nusap1. Cluster 0 also had unique specific genes, such as H2afx, Arl6ip1, Smc4, Cks2 and Cdca8. Cluster 2 did not seem to correspond to any tHSCs or tMPPs, although they shared specific genes, i.e., Nolc1 and Srm, with tMPP5 . Cluster 2 also had unique specific genes, including Hspd1, Ncl, Tomm5, Cacybp, Hsp90aa1, Lyar, Nhp2 and Set. Although cluster 3 and cluster 4 corresponded to tHSC3, they had significant enrichment of myeloid progenitor gene sets, including Hp, Prtn3, Ctsg, Elane, Ms4a3 and Ccr2. Cluster 6 expressed a high level of Pf4 and exhibited positive enrichment of the megakaryocyte progenitor cell gene sets (Fig. 5D).
The percentage of each cluster was calculated and plotted to determine whether overexpression of Fbxw11 affected the distribution of different clusters. No significant difference was detected between the LSK-Con and LSK-Fbxw11d groups (Fig. 5E). These data indicated that Fbxw11 had little effect on the composition of heterogeneous HSPC subpopulations, although it dramatically decreased the absolute number of HSPCs.
Single-cell analysis reveals the effects of Fbxw11 on the expression of genes associated with HSC maintenance and lineage differentiation
To further explore which genes are affected by Fbxw11 overexpression at single-cell level, we focused on genes that were differentially expressed between LSK-Fbxw11d and LSK-Con, especially transcription factors (TFs). Cebpa, Myc and Arid5b, which significantly regulate HSPC activity, were downregulated in almost all clusters of LSK-Fbxw11d when compared with LSK-Con (Fig. 6A). Gene set enrichment analysis (GSEA) showed enrichment of “myeloid differentiation up” in LSK-Fbxw11d compared with LSK-Con (Fig. 6B). Myeloid development-associated TFs and specific genes were also analyzed based on scRNA-seq results. Ms4a3 and Chd3, which are important for myeloid development , were highly expressed in myeloid prone subpopulations of LSK-Fbxw11d (Fig. 6C). Myeloid-associated TFs Stat3 and Etv6 were also slightly upregulated, though the percentage of positive cells was lower (Additional file 1: Fig. S6). Collectively, these results suggested that Fbxw11 might exert its regulatory effects on HSC maintenance and lineage differentiation through the regulation of self-renewal and myeloid-associated TFs.
Stem cells are required for tissue maintenance. Their self-renewal potential and pluripotency are tightly regulated by sophisticated signal transduction networks. Accumulating evidence has revealed that the self-renewal, pluripotency and differentiation of stem cells are precisely controlled by the UPS system, which controls highly ordered protein degradation [37, 38]. Abnormal proteasome activity can lead to serious consequences. The E3 ligases in the UPS act as recognition components, and different members have heterogeneous effects on stem cells by targeting diverse spectra of proteins. While abnormal control of ubiquitination contributes to the initiation and progression of malignancies, mounting evidence suggests that dysfunction of the UPS is also related to the failure of stem cell self-renewal and functions. Abnormal ubiquitination in embryonic stem cells impairs their potential to differentiate into neural cells and causes fetal death [37, 39]. Abnormal control of ubiquitination in the hematopoietic system is related to Fanconi anemia and aplastic anemia [40,41,42]. In the present study, we show that increased expression of Fbxw11 results in impaired stem cell maintenance. Our work provides a deeper understanding of the UPS-mediated regulatory mechanism in hematopoiesis.
Quiescence and differentiation are two important factors to maintain HSCs homeostasis. Quiescence is necessary for maintaining the stemness and function of HSCs under steady-state conditions. Breaking quiescence leads to HSC exhaustion and eventually causes failure of hematopoiesis . Our observations suggested that Fbxw11 decreased the quiescence of HSCs by pushing them into the cell cycle, which impaired the stemness and sustained the self-maintenance potential of HSCs. Differentiation-associated mechanisms may also be involved in this process since we got the following observations. First, GMPs expressed the highest level of Fbxw11 among HSPC subpopulations. Second, Fbxw11 increased the proportion of GMPs and CFU-GM colony in vitro, while it increased the percentage of Gr-1+CD11b+ granulocytic cells and decreased the percentage of CD3+ or B220+ lymphocytes in PB, BM and SP after transplantation in vivo. Third, Fbxw11-overexpressing LSK cells expressed higher levels of Csf1r, Csf2r, Runx1 and Stat3, which are important for myeloid development [44,45,46,47]. Fourth, GSEA results also demonstrated the enrichment of “myeloid differentiation up” associate gene. It is possible that Fbxw11 might promote myeloid differentiation of HSCs, which may also account for the impaired repopulation capacity of HSCs. Unfortunately, we do not have direct evidence, such as the GMP output after transplantation in vivo, due to the very low graft reconstruction status.
Although the UPS affects the repopulation and function of stem cells through different mechanisms, reshaping the expression spectrum of TFs is one of the most important steps. In fact, some TFs that are important for stem cells are direct targets of the UPS. The UPS maintains the balance of self-renewal and differentiation of stem cells by maintaining the stability of key TFs, such as Myc and OCT-3/4, which are directly recognized by Fbxw7 and WWP2 E3 ligases [48, 49]. However, in many cases, there is no direct link between abnormal E3 ligase and altered TFs. In these cases, UPS indirectly affects TFs through broad-spectrum and sophisticated signal transduction pathways [39, 50]. Here, we found that the expression of Cebpa, Myc and Arid5b in HSPCs was sharply decreased by elevated expression of Fbxw11. C/EBPα is an important transcriptional regulator in HSCs and plays roles not only in myeloid differentiation , but also in HSC quiescence. C/EBPα deletion was associated with a dramatic loss in HSC self-renewal. Furthermore, Cebpa−/− HSCs failed to reconstruction in secondary recipients or in irradiated mice in non-competitive transplantation experiments. Therefore, C/EBPα is indeed essential for HSC function, at least during hematopoietic reconstitution [52, 53]. Myc proteins (c-Myc and N-Myc) are downstream targets of C/EBPα and are necessary for the proliferation and survival of HSCs [54, 55]. Arid5b is a critical downstream target of TAL1 and is essential for maintaining the multipotency and quiescence of HSCs [56, 57]. Hence, Fbxw11 may cause failure of HSPCs through the downregulation of these TFs.
HSPCs are composed of hierarchically heterogeneous subpopulations . Whether Fbxw11 specifically modulates some subpopulations or has similar effects on most subpopulations has not been established. Compared with conventional bulk RNA-seq, which captures the average gene expression profile of all subpopulations, the scRNA-seq technique is capable of resolving heterogeneity among subpopulations and acquiring gene profiling at the single-cell level. Hence, scRNA-seq was carried out to reveal the heterogeneity within HSPCs as well as to show the effects of Fbxw11 on the gene expression profiles of different subpopulations. With the development of scRNA-seq techniques, several groups have revealed transcriptional profiles of HSPC subpopulations following the strategy that each predetermined subpopulation was first obtained by accurate sorting based on established surface markers before scRNA-seq [21, 22, 59]. Here, we followed another strategy in which all LSK cells underwent scRNA-seq, and cell clusters were entirely determined by gene expression profiles. We believe that this strategy more accurately reflects the nature of LSK cells since it avoids missing transitional cells and eliminates possible defects by arbitrary predetermination of HSPC subpopulations. We classified seven major cell clusters by transcriptome landscaping. Although these clusters share some identical specific genes with HSPC subpopulations reported in the literature, they also have unique specific genes. Hence, our findings contribute to a better understanding of HSPC heterogeneity and provide reference for further definition of HSPC subpopulations. Functional assays in the future will further classify these clusters. Nevertheless, an important result we obtained is that Fbxw11 has little effect on the composition of heterogeneous HSPC subpopulations, although it dramatically decreases the absolute number of HSPCs, suggesting that Fbxw11 may have similar effects on all HSPC subpopulations. The observation that C/EBPα, Myc and Arid5b, self-renewal-associated TFs, were downregulated in all HSPC clusters overexpressing Fbxw11 further confirmed this conclusion. The above results suggest that elevated Fbxw11-related UPS decreases the self-renewal potential of all HSPC subpopulations, which results in the failure of HSCs and low graft reconstruction.
In summary, our work elucidates the novel role of Fbxw11 in the regulation of HSPCs and reveals the transcriptomic heterogeneity of HSPCs at the single-cell level. High-level expression of Fbxw11 decreased the expression of key molecules in the regulation of self-renewal of HSPCs, i.e., C/EBPα, Myc and Arid5b, in all HSPC subpopulations; reduced quiescence and reconstruction of HSPCs; and finally caused failure of HSCs. These results provide additional views on the role of ubiquitin in hematopoietic stem cell maintenance.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Hematopoietic stem/progenitor cells
Single-cell RNA sequencing
Hematopoietic stem cells
Long-term hematopoietic stem cells
Short-term hematopoietic stem cells
Common myeloid progenitors
Common lymphoid progenitors
Gene Expression Omnibus
Differentially expressed genes
Gene set enrichment analysis
Höfer T, Rodewald HR. Differentiation-based model of hematopoietic stem cell functions and lineage pathways. Blood. 2018;132:1106–13. https://doi.org/10.1182/blood-2018-03-791517.
Zon LI. Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal. Nature. 2008;453:306–13. https://doi.org/10.1038/nature07038.
Wang X, Gao Y, Gao J, Li M, Zhou M, Wang J, Pang Y, Cheng H, Yuan C, Chu Y, Jiang Y, Zhou J, Luo HR, Ju Z, Cheng T, Yuan W. Rheb1 loss leads to increased hematopoietic stem cell proliferation and myeloid-biased differentiation in vivo. Haematologica. 2019;104:245–55. https://doi.org/10.3324/haematol.2018.194811.
Zhang Y, Zhang J, An W, Wan Y, Ma S, Yin J, Li X, Gao J, Yuan W, Guo Y, Engel JD, Shi L, Cheng T, Zhu X. Intron 1 GATA site enhances ALAS2 expression indispensably during erythroid differentiation. Nucleic Acids Res. 2017;45:657–71. https://doi.org/10.1093/nar/gkw901.
Seita J, Weissman IL. Hematopoietic stem cell: self-renewal versus differentiation. Wiley Interdiscip Rev Syst Biol Med. 2010;2:640–53. https://doi.org/10.1002/wsbm.86.
Mukhopadhyay D, Riezman H. Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science. 2007;315:201–5. https://doi.org/10.1126/science.1127085.
Metzger MB, Hristova VA, Weissman AM. HECT and RING finger families of E3 ubiquitin ligases at a glance. J Cell Sci. 2012;125:531–7. https://doi.org/10.1242/jcs.091777.
Kitagawa K, Kitagawa M. The SCF ubiquitin ligases involved in hematopoietic lineage. Curr Drug Targets. 2012;13:1641–8. https://doi.org/10.2174/138945012803529974.
Iriuchishima H, Takubo K, Matsuoka S, Onoyama I, Nakayama KI, Nojima Y, Suda T. Ex vivo maintenance of hematopoietic stem cells by quiescence induction through Fbxw7α overexpression. Blood. 2011;117:2373–7. https://doi.org/10.1182/blood-2010-07-294801.
Ueda T, Nagamachi A, Takubo K, Yamasaki N, Matsui H, Kanai A, Nakata Y, Ikeda K, Konuma T, Oda H, Wolff L, Honda Z, Wu X, Helin K, Iwama A, Suda T, Inaba T, Honda H. Fbxl10 overexpression in murine hematopoietic stem cells induces leukemia involving metabolic activation and upregulation of Nsg2. Blood. 2015;125:3437–46. https://doi.org/10.1182/blood-2014-03-562694.
Chen BB, Glasser JR, Coon TA, Zou C, Miller HL, Fenton M, McDyer JF, Boyiadzis M, Mallampalli RK. F-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferation. Blood. 2012;119:3132–41. https://doi.org/10.1182/blood-2011-06-358911.
Chen JY, Wang MC, Hung WC. Bcr-Abl-induced tyrosine phosphorylation of Emi1 to stabilize Skp2 protein via inhibition of ubiquitination in chronic myeloid leukemia cells. J Cell Physiol. 2011;226:407–13. https://doi.org/10.1002/jcp.22346.
Takeishi S, Matsumoto A, Onoyama I, Naka K, Hirao A, Nakayama KI. Ablation of Fbxw7 eliminates leukemia-initiating cells by preventing quiescence. Cancer Cell. 2013;23:347–61. https://doi.org/10.1016/j.ccr.2013.01.026.
King B, Trimarchi T, Reavie L, Xu L, Mullenders J, Ntziachristos P, Aranda-Orgilles B, Perez-Garcia A, Shi J, Vakoc C, Sandy P, Shen SS, Ferrando A, Aifantis I. The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability. Cell. 2013;153:1552–66. https://doi.org/10.1016/j.cell.2013.05.041.
Duan S, Cermak L, Pagan JK, Rossi M, Martinengo C, di Celle PF, Chapuy B, Shipp M, Chiarle R, Pagano M. FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas. Nature. 2012;481:90–3. https://doi.org/10.1038/nature10688.
Yao J, Yang J, Yang Z, Wang XP, Yang T, Ji B, Zhang ZY. FBXW11 contributes to stem-cell-like features and liver metastasis through regulating HIC1-mediated SIRT1 transcription in colorectal cancer. Cell Death Dis. 2021;12:930. https://doi.org/10.1038/s41419-021-04185-7.
Holt RJ, Young RM, Crespo B, Ceroni F, Curry CJ, Bellacchio E, Bax DA, Ciolfi A, Simon M, Fagerberg CR, van Binsbergen E, De Luca A, Memo L, Dobyns WB, Mohammed AA, Clokie SJH, Zazo Seco C, Jiang YH, Sørensen KP, Andersen H, Sullivan J, Powis Z, Chassevent A, Smith-Hicks C, Petrovski S, Antoniadi T, Shashi V, Gelb BD, Wilson SW, Gerrelli D, Tartaglia M, Chassaing N, Calvas P, Ragge NK. De novo missense variants in FBXW11 cause diverse developmental phenotypes including brain, eye, and digit anomalies. Am J Hum Genet. 2019;105:640–57. https://doi.org/10.1016/j.ajhg.2019.07.005.
Wang L, Feng W, Yang X, Yang F, Wang R, Ren Q, Zhu X, Zheng G. Fbxw11 promotes the proliferation of lymphocytic leukemia cells through the concomitant activation of NF-kappaB and beta-catenin/TCF signaling pathways. Cell Death Dis. 2018;9:427. https://doi.org/10.1038/s41419-018-0440-1.
Oguro H, Ding L, Morrison SJ. SLAM family markers resolve functionally distinct subpopulations of hematopoietic stem cells and multipotent progenitors. Cell Stem Cell. 2013;13:102–16. https://doi.org/10.1016/j.stem.2013.05.014.
Pellin D, Loperfido M, Baricordi C, Wolock SL, Montepeloso A, Weinberg OK, Biffi A, Klein AM, Biasco L. A comprehensive single cell transcriptional landscape of human hematopoietic progenitors. Nat Commun. 2019;10:2395. https://doi.org/10.1038/s41467-019-10291-0.
Nestorowa S, Hamey FK, Pijuan Sala B, Diamanti E, Shepherd M, Laurenti E, Wilson NK, Kent DG, Göttgens B. A single-cell resolution map of mouse hematopoietic stem and progenitor cell differentiation. Blood. 2016;128:e20-31. https://doi.org/10.1182/blood-2016-05-716480.
Dong F, Hao S, Zhang S, Zhu C, Cheng H, Yang Z, Hamey FK, Wang X, Gao A, Wang F, Gao Y, Dong J, Wang C, Wang J, Lan Y, Liu B, Ema H, Tang F, Göttgens B, Zhu P, Cheng T. Differentiation of transplanted haematopoietic stem cells tracked by single-cell transcriptomic analysis. Nat Cell Biol. 2020;6:630–9. https://doi.org/10.1038/s41556-020-0512-1.
Zhou J, Liu B, Lan Y. When blood development meets single-cell transcriptomics. Blood Sci. 2019;1:65–8. https://doi.org/10.1097/bs9.0000000000000007.
Feng W, Yang X, Wang L, Wang R, Yang F, Wang H, Liu X, Ren Q, Zhang Y, Zhu X, Zheng G. P2X7 promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of Pbx3. Haematologica. 2021;106:1278–89. https://doi.org/10.3324/haematol.2019.243360.
Yang X, Feng W, Wang R, Yang F, Wang L, Chen S, Ru Y, Cheng T, Zheng G. Repolarizing heterogeneous leukemia-associated macrophages with more M1 characteristics eliminates their pro-leukemic effects. Oncoimmunology. 2018;7:e1412910. https://doi.org/10.1080/2162402x.2017.1412910.
Lara-Astiaso D, Weiner A, Lorenzo-Vivas E, Zaretsky I, Jaitin DA, David E, Keren-Shaul H, Mildner A, Winter D, Jung S, Friedman N, Amit I. Immunogenetics. Chromatin state dynamics during blood formation. Science. 2014;345:943–9. https://doi.org/10.1126/science.1256271.
Wang R, Feng W, Wang H, Wang L, Yang X, Yang F, Zhang Y, Liu X, Zhang D, Ren Q, Feng X, Zheng G. Blocking migration of regulatory T cells to leukemic hematopoietic microenvironment delays disease progression in mouse leukemia model. Cancer Lett. 2020;469:151–61. https://doi.org/10.1016/j.canlet.2019.10.032.
Yang F, Wang R, Feng W, Chen C, Yang X, Wang L, Hu Y, Ren Q, Zheng G. Characteristics of NK cells from leukemic microenvironment in MLL-AF9 induced acute myeloid leukemia. Mol Immunol. 2018;93:68–78. https://doi.org/10.1016/j.molimm.2017.11.003.
Chen SY, Yang X, Feng WL, Liao JF, Wang LN, Feng L, Lin YM, Ren Q, Zheng GG. Organ-specific microenvironment modifies diverse functional and phenotypic characteristics of leukemia-associated macrophages in mouse T cell acute lymphoblastic leukemia. J Immunol. 2015;194:2919–29. https://doi.org/10.4049/jimmunol.1400451.
Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics (Oxford, England). 2014;30:2114–20. https://doi.org/10.1093/bioinformatics/btu170.
Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics (Oxford, England). 2013;29:15–21. https://doi.org/10.1093/bioinformatics/bts635.
Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM 3rd, Hao Y, Stoeckius M, Smibert P, Satija R. Comprehensive integration of single-cell data. Cell. 2019;177:1888–902. https://doi.org/10.1016/j.cell.2019.05.031.
Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, Lennon NJ, Livak KJ, Mikkelsen TS, Rinn JL. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32:381–6. https://doi.org/10.1038/nbt.2859.
Nakagawa T, Araki T, Nakagawa M, Hirao A, Unno M, Nakayama K. S6 kinase- and beta-TrCP2-dependent degradation of p19Arf Is required for cell proliferation. Mol Cell Biol. 2015;35:3517–27. https://doi.org/10.1128/MCB.00343-15.
Koike J, Sagara N, Kirikoshi H, Takagi A, Miwa T, Hirai M, Katoh M. Molecular cloning and genomic structure of the betaTRCP2 gene on chromosome 5q35.1. Biochem Biophys Res Commun. 2000;269:103–9. https://doi.org/10.1006/bbrc.2000.2241.
Liu Z, Gu Y, Chakarov S, Bleriot C, Kwok I, Chen X, Shin A, Huang W, Dress RJ, Dutertre CA, Schlitzer A, Chen J, Ng LG, Wang H, Liu Z, Su B, Ginhoux F. Fate mapping via Ms4a3-expression history traces monocyte-derived cells. Cell. 2019;178:1509–25. https://doi.org/10.1016/j.cell.2019.08.009.
Vilchez D, Boyer L, Morantte I, Lutz M, Merkwirth C, Joyce D, Spencer B, Page L, Masliah E, Berggren WT, Gage FH, Dillin A. Increased proteasome activity in human embryonic stem cells is regulated by PSMD11. Nature. 2012;489:304–8. https://doi.org/10.1038/nature11468.
Jiang P, Wang H, Zheng J, Han Y, Huang H, Qian P. Epigenetic regulation of hematopoietic stem cell homeostasis. Blood Sci. 2019;1:19–28. https://doi.org/10.1097/bs9.0000000000000018.
Saez I, Koyuncu S, Gutierrez-Garcia R, Dieterich C, Vilchez D. Insights into the ubiquitin–proteasome system of human embryonic stem cells. Sci Rep. 2018;8:4092. https://doi.org/10.1038/s41598-018-22384-9.
Lv K, Jiang J, Donaghy R, Riling CR, Cheng Y, Chandra V, Rozenova K, An W, Mohapatra BC, Goetz BT, Pillai V, Han X, Todd EA, Jeschke GR, Langdon WY, Kumar S, Hexner EO, Band H, Tong W. CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies. Genes Dev. 2017;31:1007–23. https://doi.org/10.1101/gad.297135.117.
Li H, Xu X, Wang D, Zeng L, Li B, Zhang Y, Su S, Wei L, You H, Fang Y, Wang Y, Liu Y. miR-146b-5p regulates bone marrow mesenchymal stem cell differentiation by SIAH2/PPARγ in aplastic anemia children and benzene-induced aplastic anemia mouse model. Cell Cycle. 2020;19:1–12. https://doi.org/10.1080/15384101.2020.1807081.
Nagareddy B, Khan A, Kim H. Acetylation modulates the Fanconi anemia pathway by protecting FAAP20 from ubiquitin-mediated proteasomal degradation. J Biol Chem. 2020;40:13887–901. https://doi.org/10.1074/jbc.RA120.015288.
Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, Sykes M, Scadden DT. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science. 2000;287:1804–8. https://doi.org/10.1126/science.287.5459.1804.
Stanley ER, Chitu V. CSF-1 receptor signaling in myeloid cells. Cold Spring Harb Perspect Biol. 2014;6:a021857. https://doi.org/10.1101/cshperspect.a021857.
Yan W-L, Shen K-Y, Tien C-Y, Chen Y-A, Liu S-J. Recent progress in GM-CSF-based cancer immunotherapy. Immunotherapy. 2017;9:347–60. https://doi.org/10.2217/imt-2016-0141.
Zhao H, Wang X, Yi P, Si Y, Tan P, He J, Yu S, Ren Y, Ma Y, Zhang J, Wang D, Wang F, Yu J. KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression. Nat Commun. 2017;8:1428. https://doi.org/10.1038/s41467-017-01425-3.
Chakraborty A, Tweardy DJ. Stat3 and G-CSF-induced myeloid differentiation. Leuk Lymphoma. 1998;30:433–42. https://doi.org/10.3109/10428199809057555.
Baek KH, Choi J, Pei CZ. Cellular functions of OCT-3/4 regulated by ubiquitination in proliferating cells. Cancers. 2020;12:663. https://doi.org/10.3390/cancers12030663.
Zhao X, Heng JI, Guardavaccaro D, Jiang R, Pagano M, Guillemot F, Iavarone A, Lasorella A. The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein. Nat Cell Biol. 2008;10:643–53. https://doi.org/10.1038/ncb1727.
Naujokat C, Sarić T. Concise review: role and function of the ubiquitin–proteasome system in mammalian stem and progenitor cells. Stem Cells. 2007;25:2408–18. https://doi.org/10.1634/stemcells.2007-0255.
Avellino R, Havermans M, Erpelinck C, Sanders MA, Hoogenboezem R, van de Werken HJ, Rombouts E, van Lom K, van Strien PM, Gebhard C, Rehli M, Pimanda J, Beck D, Erkeland S, Kuiken T, de Looper H, Groschel S, Touw I, Bindels E, Delwel R. An autonomous CEBPA enhancer specific for myeloid-lineage priming and neutrophilic differentiation. Blood. 2016;127:2991–3003. https://doi.org/10.1182/blood-2016-01-695759.
Hasemann MS, Lauridsen FK, Waage J, Jakobsen JS, Frank AK, Schuster MB, Rapin N, Bagger FO, Hoppe PS, Schroeder T, Porse BT. C/EBPalpha is required for long-term self-renewal and lineage priming of hematopoietic stem cells and for the maintenance of epigenetic configurations in multipotent progenitors. PLoS Genet. 2014;10:e1004079. https://doi.org/10.1371/journal.pgen.1004079.
Ohlsson E, Schuster MB, Hasemann M, Porse BT. The multifaceted functions of C/EBPα in normal and malignant haematopoiesis. Leukemia. 2016;30:767–75. https://doi.org/10.1038/leu.2015.324.
Ye M, Zhang H, Amabile G, Yang H, Staber PB, Zhang P, Levantini E, Alberich-Jorda M, Zhang J, Kawasaki A, Tenen DG. C/EBPa controls acquisition and maintenance of adult haematopoietic stem cell quiescence. Nat Cell Biol. 2013;15:385–94. https://doi.org/10.1038/ncb2698.
Laurenti E, Varnum-Finney B, Wilson A, Ferrero I, Blanco-Bose WE, Ehninger A, Knoepfler PS, Cheng PF, MacDonald HR, Eisenman RN, Bernstein ID, Trumpp A. Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity. Cell Stem Cell. 2008;3:611–24. https://doi.org/10.1016/j.stem.2008.09.005.
Leong WZ, Tan SH, Ngoc PCT, Amanda S, Yam AWY, Liau WS, Gong Z, Lawton LN, Tenen DG, Sanda T. ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis. Genes Dev. 2017;31:2343–60. https://doi.org/10.1101/gad.302646.117.
Vagapova ER, Spirin PV, Lebedev TD, Prassolov VS. The role of TAL1 in hematopoiesis and leukemogenesis. Acta Naturae. 2018;10:15–23.
Zhang S, O’Neill A, Xie M, Wu P, Wang X, Bai H, Dong F, Wang J, Zhang Q, Suda T, Ema H. Lymphoid-biased hematopoietic stem cells and myeloid-biased hematopoietic progenitor cells have radioprotection activity. Blood Sci. 2021;3:113–21. https://doi.org/10.1097/bs9.0000000000000089.
Xie X, Liu M, Zhang Y, Wang B, Zhu C, Wang C, Li Q, Huo Y, Guo J, Xu C, Hu L, Pang A, Ma S, Wang L, Cao W, Chen S, Li Q, Zhang S, Zhao X, Zhou W, Luo H, Zheng G, Jiang E, Feng S, Chen L, Shi L, Cheng H, Hao S, Zhu P, Cheng T. Single-cell transcriptomic landscape of human blood cells. Natl Sci Rev. 2021;8:nwaa180. https://doi.org/10.1093/nsr/nwaa180.
This work was supported by grants 81300376 to L.W. and 81970155 and 82170174 to G.Z. from the National Natural Science Foundation of China (NSFC); program 2021YFA1100703 to L.W. from National Key Research and Development Program of China; programs 2017-I2M-1-015 to L.W. and 2021-I2M-1-041 to G.Z. from the CAMS Innovation Fund for Medical Sciences (CIFMS); State Key Laboratory of Experimental Hematology Research Grant (Z20-06) to G.Z.; G.Z. is a recipient of the New Century Excellent Talents in University (NCET-08-0329).
Ethics approval and consent to participate
The study was conducted along the guidelines set by the Institutional Animal Care and Use Committee of Institute of Hematology & Blood Disease Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The strategies to analyze and sort hematopoietic cell populations used in this study by FACS are shown. (A) LK cells, LSK cells, LT-HSCs, ST-HSCs, MPPs, CMPs, GMPs, MEPs were sorted after enrichment using c-Kit+ magnetic beads. (B) Common lymphoid progenitors (CLPs) were also sorted after enrichment using c-Kit+ magnetic beads. (C) Gating strategy of granulocytes. (D) Gating strategy of monocytes and macrophages. (E) Gating strategy of B cells and T cells. (F) Gating strategy of NK cells. Fig. S2. (A) Lethally irradiated C57BL/6 mice were transplanted with 1 × 106 GFP+ LK cells (Lin- c-Kit+) from the control and Fbxw11 groups. Cells homing to the BM were analyzed by FACS 16 hours after transplantation (control: n = 3; Fbxw11d: n = 7). (B–D) The overall reconstitution status (including both GFP+ cells and competitor cells) was assessed at the 1st, 3rd, and 5th month. (E) The percentage of donor LSK cells in BM at the 5th month after first-round transplantation was analyzed by FACS, n = 3. Fig. S3. Violin plots show the expression of cluster-specific genes of each cluster in all clusters. For cluster 0 to cluster 3, only the top 10 cluster-specific genes are shown. Fig. S4. The heatmaps show the expression of population-specific genes of transcriptionally defined HSPC populations from published references in LSK-Con and LSK-Fbxw11d (Dong’s paper, PMID: 32367048). Fig. S5. Expression of cluster 1-specific genes (Ltb, Myct1 and Serpina3g) in LT-HSCs in the published reference model (Nestorowa’s paper, PMID: 27365425). Fig. S6. Violin plots demonstrate the expression of Stat3, Etv6 and Chd3 in clusters from LSK-C and LSK-F11D. *p < 0.05, **p < 0.01, ***p < 0.001.
Primers used for detection of mouse genes by real-time RT-PCR analysis.
About this article
Cite this article
Wang, L., Piao, Y., Zhang, D. et al. Fbxw11 impairs the repopulation capacity of hematopoietic stem/progenitor cells. Stem Cell Res Ther 13, 245 (2022). https://doi.org/10.1186/s13287-022-02926-9
- Hematopoietic stem cell
- Hematopoietic progenitor cell
- Single-cell RNA sequencing